{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:47:09Z","timestamp":1770068829896,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.cardfail.2004.02.006","type":"journal-article","created":{"date-parts":[[2004,4,20]],"date-time":"2004-04-20T15:58:16Z","timestamp":1082476696000},"page":"101-112","source":"Crossref","is-referenced-by-count":83,"title":["The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics"],"prefix":"10.1016","volume":"10","author":[{"given":"Barry M.","family":"Massie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William F.","family":"Krol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Ammon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph F.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ezekowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed M.","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milton","family":"Packer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin A.","family":"Schulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koon","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Warren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2004.02.006_BIB1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00007611-194804000-00018","article-title":"The use of dicumarol as an adjunct to the treatment of congestive heart failure","volume":"41","author":"Anderson","year":"1948","journal-title":"South Med J"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM194811042391902","article-title":"Dicumarol therapy in congestive heart failure","volume":"239","author":"Wishart","year":"1948","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1056\/NEJM195002092420603","article-title":"Dicumarol prophylaxis of thromboembolic disease in congestive heart failure","volume":"242","author":"Harvey","year":"1950","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB4","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-37-5-867","article-title":"A study of the beneficial effects of anticoagulant therapy in congestive heart failure","volume":"37","author":"Griffith","year":"1952","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0146-2806(78)90026-9","article-title":"Idiopathic cardiomyopathy: clinical features, prognosis, and therapy","volume":"3","author":"Segal","year":"1978","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9149(81)90534-8","article-title":"The natural history of idiopathic dilated cardiomyopathy","volume":"47","author":"Fuster","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1055\/s-0038-1657888","article-title":"Prevention of arterial and pulmonary embolism by oral anticoagulation in patients with dilated cardiomyopathy","volume":"54","author":"Kyrl","year":"1985","journal-title":"Thromb Haemost"},{"issue":"Suppl I","key":"10.1016\/j.cardfail.2004.02.006_BIB8","first-page":"I-252","article-title":"Risk of thromboembolism in left ventricular dysfunction. SOLVD","volume":"86","author":"Cohn","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB9","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0735-1097(97)00019-3","article-title":"Ejection fraction and the risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm","volume":"29","author":"Dries","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl VI","key":"10.1016\/j.cardfail.2004.02.006_BIB10","first-page":"VI-94","article-title":"Incidence of thromboembolic events in congestive heart failure","volume":"87","author":"Dunkman","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB11","first-page":"1449","article-title":"Risk factors for stroke and efficacy on antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials","author":"Atrial Fibrillation Investigators","year":"1994","journal-title":"Arch Int Med"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/hrt.62.1.26","article-title":"Lack of correlation between intracavitary thrombosis detected by cross sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy","volume":"62","author":"Ciaccheri","year":"1989","journal-title":"Br Heart J"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00043798-199504000-00003","article-title":"Left ventricular thrombus and the incidence of thromboembolism in patients with congestive heart failure: can clinical factors identify patients at increased risk?","volume":"2","author":"Katz","year":"1995","journal-title":"J Cardiovascular Risk"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB14","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/oxfordjournals.eurheartj.a015073","article-title":"Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients","volume":"17","author":"Cioffi","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00001573-199705000-00009","article-title":"Anticoagulant and Antiplatelet therapy in heart failure","volume":"12","author":"Cleland","year":"1997","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1071-9164(98)90502-4","article-title":"Regional differences in the characteristics and treatment of patients participating in an international heart failure trial","volume":"4","author":"Massie","year":"1998","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB17","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.1994.03520200070038","article-title":"Management of heart failure","volume":"272","author":"Baker","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/qjmed\/95.7.451","article-title":"Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review","author":"Lip","year":"2002","journal-title":"Quart J Med"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB19","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0735-1097(01)01683-7","article-title":"ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary","volume":"38","author":"Hunt","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB20","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1053\/euhj.2001.2783","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure","volume":"22","author":"Task Force for the Diagnosis and Treatment of Chronic Heart Failure","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00127408","article-title":"Is there a role for warfarin or aspirin therapy in heart failure?","volume":"1","author":"Jafri","year":"1996","journal-title":"Heart Failure Rev"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0033-0620(98)80057-1","article-title":"Antiplatelet and anticoagulant therapy in the prevention of thrombemboli in chronic heart failure","volume":"41","author":"Garg","year":"1998","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB23","first-page":"1424","article-title":"Does heart failure confer a hypercoagulable state? Virchow's triad revisited","volume":"33","author":"Lip","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0167-5273(00)00300-4","article-title":"Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge","volume":"75","author":"Davis","year":"2000","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.CIR.102.6.611","article-title":"Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial","volume":"102","author":"Uretsky","year":"2000","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1016\/j.cardfail.2004.02.006_BIB26","first-page":"1S","article-title":"Sixth ACCP Consensus Conference on Antithrombotic Therapy","volume":"119","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Warfarin, aspirin, or both after myocardial infarction. WARIS I and ASPECT I","volume":"347","author":"Hurlen","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(02)09409-6","article-title":"Aspirin and Coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial","volume":"360","author":"Van Es","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0735-1097(97)00502-0","article-title":"Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial","volume":"31","author":"Al-Khadra","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0735-1097(98)00006-0","article-title":"Warfarin anticoagulation and survival: a cohort analysis from the studies of left ventricular dysfunction","volume":"31","author":"Al-Khadra","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-8703(99)70099-2","article-title":"The interaction of ACE inhibitors and aspirin in heart failure: torn between two lovers","volume":"138","author":"Teerlink","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9343(00)00579-9","article-title":"Interaction between aspirin and angiotensin-converting enzyme inhibitors: real or imagined","volume":"109","author":"Massie","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9149(96)00696-0","article-title":"Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative North Scandinavian Enalapril Survival Study II","volume":"79","author":"Nguyen","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB35","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/archinte.163.13.1574","article-title":"Aspirin-angiotensin-converting enzyme inhibitor co-administration and mortality in patients with heart failure. A dose-related adverse effect of aspirin","volume":"163","author":"Guazzi","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB36","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/S0735-1097(00)00637-9","article-title":"The aspirin-angiotensin-converting enzyme inhibitor tradeoff: to halve and halve not","volume":"35","author":"Hall","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00002018-200124030-00002","article-title":"Interaction between aspirin and ACE inhibitors in patients with heart failure","volume":"24","author":"Mah\u00e9","year":"2001","journal-title":"Drug Safety"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB38","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archinte.160.10.1409","article-title":"Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure?","volume":"160","author":"Stys","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB39","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0735-1097(00)00638-0","article-title":"Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin","volume":"35","author":"Latini","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB40","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(02)11138-X","article-title":"Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review","volume":"360","author":"Teo","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM198402093100603","article-title":"Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponatremia","volume":"310","author":"Dzau","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB42","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/0735-1097(92)90449-W","article-title":"Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure","volume":"20","author":"Hall","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB43","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/01.CIR.98.8.757","article-title":"Acute hemodynamic interaction of aspirin and ticlopidine with enalapril","volume":"98","author":"Spaulding","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/hrt.73.3.227","article-title":"Combining salicylate and enalapril in patients with coronary artery disease and heart failure","volume":"73","author":"Baur","year":"1995","journal-title":"Br Heart J"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB45","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0002-9149(99)80305-1","article-title":"Effect of long-term angiotensin inhibition on vascular function in patients with chronic congestive heart failure","volume":"76","author":"Jeserich","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB46","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1067\/mcp.2000.106290","article-title":"Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failure","volume":"67","author":"Davie","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB47","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1388-9842(99)00059-8","article-title":"Meeting report: the LIDO, HOPE, MOXCON and WASH studies","volume":"1","author":"Jones","year":"1999","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB48","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE)","volume":"348","author":"The CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)01180-X","article-title":"Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction","volume":"350","author":"Coumadin Aspirin Reinfarction Study (CARS) Investigator","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/hc0502.103329","article-title":"Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study","volume":"105","author":"Fiore","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2004.02.006_BIB51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQoL\u2014the current state of play","volume":"37","author":"Brooks","year":"1996","journal-title":"Health Policy"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916404000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916404000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T13:44:08Z","timestamp":1585748648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916404000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S1071916404000533"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2004.02.006","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}